03.15.23 -- Essential Tools And Tactics For A Successful Hybrid Trial

Interactive response technology is expected to play an increasingly significant role in addressing the complex challenges of drug management and distribution for decentralized and hybrid clinical trials. Discover how IRTs are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.

The proliferation of both patient-centric and hybrid clinical trials has created a need for more individualized, simplified, and accessible processes involving trial participants. Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.

Successful organizations and studies align protocol, patient type, and therapeutic area by collaborating with partners to minimize burdens and risk while maximizing the effectiveness of technologies applied. Consider this collection of DCT solutions when working to identify and prioritize strategy or technology efficiencies and avoid complex issues.